The role of intravascular devices in sepsis

被引:44
作者
Christopher J. Crnich
Dennis G. Maki
机构
[1] H4/572 University of Wisconsin Hospital and Clinics,
关键词
Systemic Inflammatory Response Syndrome; Bloodstream Infection; Maki; Infect Control Hosp; Hemodialysis Catheter;
D O I
10.1007/s11908-001-0086-4
中图分类号
学科分类号
摘要
Intravascular devices (IVDs) are widely used in modern day health care. Unfortunately, their use is associated with substantial risk of bloodstream infection (BSI) and sepsis, with increased hospitalization and hospital mortality. IVDs are the most common cause of nosocomial BSI. The wider use of new methodologies for diagnosis of IVD-related infection should allow earlier and more focused therapy and, especially, improve the accuracy of surveillance. Of all nosocomial infections, IVD-related BSIs are most amendable to prevention.
引用
收藏
页码:496 / 506
页数:10
相关论文
共 182 条
  • [1] Mermel LA(2000)Prevention of intravascular catheter-related infections Ann Intern Med 132 391-402
  • [2] Maki DG(1994)A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management Crit Care Med 22 1729-1737
  • [3] Stolz SS(1997)Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial Ann Intern Med 127 257-266
  • [4] Wheeler S(1986)A prospective study of the mechanisms of infection associated with hemodialysis catheters J Infect Dis 154 579-589
  • [5] Mermel LA(1988)Bacteraemia related to indwelling central venous catheters: prevention, diagnosis and treatment Eur J Clin Microbiol Infect Dis 7 125-129
  • [6] Maki DG(1988)CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 128-140
  • [7] Stolz SM(1997)Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group Ann Intern Med 127 267-274
  • [8] Wheeler S(1992)Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1644-1655
  • [9] Mermel LA(1995)The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study JAMA 273 117-123
  • [10] Cheesbrough JS(2000)Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations Crit Care Clin 16 179-192